Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rudikoff

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
The Journal of Biological Chemistry|February 15, 1987
Purification and properties of Gal repressor:pL-galR fusion in pKC31 plasmid vectorA Majumdar, S Rudikoff, S Adhya
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1979
The structural basis of a hapten-inhibitable kappa-chain idiotypeM Vrana, S Rudikoff, M Potter
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1982
kappa-Chain restriction in anti-galactan antibodiesM Pawlita, M Potter, S Rudikoff
Human Gene Therapy|February 11, 1998
Interleukin-2-mediated modulation of plasma cell tumor growth in a model of multiple myelomaE Kopantzev, V Roschke, S Rudikoff
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1976
Localized deletion-insertion mutations: a major factor in the evolution of immunoglobulin structural variabilityM Potter, E Padlan, S Rudikoff
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1978
Sequence variation among heavy chains from inulin-binding myeloma proteinsM Vrana, S Rudikoff, M Potter
Biochemistry|December 12, 1978
k Chain variable regions from three galactan binding myeloma proteinsD N Rao, S Rudikoff, M Potter
The Journal of Experimental Medicine|December 1, 1986
Gene correction in the evolution of the T cell receptor beta chainE Jouvin-Marche, M Heller, S Rudikoff
International Journal of Cancer|September 25, 1997
Characterization of C57BL/6 plasmacytomas lacking a c-myc translocationJ G Pumphrey, P Hausner, S Rudikoff
Medical Oncology (Northwood, London, England)|August 24, 1999
Assessment of all-trans retinoic acid (ATRA) efficacy as a single agent in primary lymphoid neoplasiaN Swaminathan, G Lopez-Berestein, S Rudikoff
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
The Journal of Biological Chemistry|February 15, 1987
Purification and properties of Gal repressor:pL-galR fusion in pKC31 plasmid vectorA Majumdar, S Rudikoff, S Adhya
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1979
The structural basis of a hapten-inhibitable kappa-chain idiotypeM Vrana, S Rudikoff, M Potter
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1982
kappa-Chain restriction in anti-galactan antibodiesM Pawlita, M Potter, S Rudikoff
Human Gene Therapy|February 11, 1998
Interleukin-2-mediated modulation of plasma cell tumor growth in a model of multiple myelomaE Kopantzev, V Roschke, S Rudikoff
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1976
Localized deletion-insertion mutations: a major factor in the evolution of immunoglobulin structural variabilityM Potter, E Padlan, S Rudikoff
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1978
Sequence variation among heavy chains from inulin-binding myeloma proteinsM Vrana, S Rudikoff, M Potter
Biochemistry|December 12, 1978
k Chain variable regions from three galactan binding myeloma proteinsD N Rao, S Rudikoff, M Potter
The Journal of Experimental Medicine|December 1, 1986
Gene correction in the evolution of the T cell receptor beta chainE Jouvin-Marche, M Heller, S Rudikoff
International Journal of Cancer|September 25, 1997
Characterization of C57BL/6 plasmacytomas lacking a c-myc translocationJ G Pumphrey, P Hausner, S Rudikoff
Medical Oncology (Northwood, London, England)|August 24, 1999
Assessment of all-trans retinoic acid (ATRA) efficacy as a single agent in primary lymphoid neoplasiaN Swaminathan, G Lopez-Berestein, S Rudikoff
Pageof 13